A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia)

PHASE2CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

October 11, 2004

Primary Completion Date

January 5, 2006

Study Completion Date

January 5, 2006

Conditions
Neuralgia, Postherpetic
Interventions
DRUG

Placebo

Daily oral dose of two equal intakes.

DRUG

Brivaracetam

Daily oral dose of two equal intakes.

Trial Locations (50)

Unknown

Brussels

Eeklo

Genk

Liège

Lubbeek (Pellenberg)

Pleven

Sofia

Varna

Hradec Králové

Prague

Svitavy

Ústí nad Labem

Annecy

Clermont-Ferrand

Nice

Toulouse

Voiron

Bad Wörishofen

Bochum

Essen

Kassel

Rodgau

Gdansk

Grudziądz

Katowice

Kielce

Krakow

Lublin

Olsztyn

Poznan

Warsaw

Wroclaw

Zgierz

Belgarde

Belgrade

Kragujevac

Bratislava

Dubnica nad Váhom

Košice

Nitra

Cadiz

Granada

Hospitalet de Llobregat (Barcelona)

Madrid

Sant Cugat Del Valles (Barcelona)

Valencia

Bath

Glasgow

London

Winchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

UCB Pharma

INDUSTRY